Huang Jinzhu, Wang Shiwei, Lu Xiaoxue, Suo Liangpeng, Wang Minyang, Yue Juanjuan, Lin Rong, Mao Xuhu, Li Qian, Yan Jingmin
Department of Clinical Microbiology and Immunology, College of Pharmacy and Medical Laboratory, Army Medical University (Third Military Medical University), Chongqing 400038, China.
Department of Pneumology, People's Hospital of Sanya, Sanya 572022, China.
Infect Med (Beijing). 2024 Nov 8;3(4):100150. doi: 10.1016/j.imj.2024.100150. eCollection 2024 Dec.
is a gram-negative bacterium widely found in Southeast Asia and northern Australia. This bacterium, which lacks an available vaccine, is the causative agent of melioidosis and has properties that potentially enable its exploitation as a bioweapon.
Polymerase chain reaction assays targeting each of the lipopolysaccharide (LPS) genetic types were used to investigate genotype frequencies in populations. Silver staining, gas chromatography-mass spectrometry (GC-MS), and immunofluorescence were used to characterize LPS.
In our study, a total of 169 clinical isolates were collected from Hainan Province, China between 2004 and 2016. The results showed that LPS genotype A was the predominant type, comprising 91.1% of the samples, compared with only 8.9% of LPS genotype B. The majority of patients were male and were diagnosed with sepsis or pneumonia. Silver staining and GC-MS demonstrated that LPS genotypes A and B exhibited distinct phenotypes and molecular structures. Immunofluorescence tests showed there was no cross-reaction between LPS genotypes A and B.
This is the first report on the molecular epidemiology of based on O-antigen in China. Tracking the regional distribution of different LPS genotypes offers significant insights relevant to the development and administration of LPS-based vaccines.
是一种革兰氏阴性菌,在东南亚和澳大利亚北部广泛存在。这种细菌缺乏可用疫苗,是类鼻疽的病原体,具有可能使其被用作生物武器的特性。
针对每种脂多糖(LPS)基因类型的聚合酶链反应检测用于调查人群中的基因型频率。银染、气相色谱 - 质谱联用(GC - MS)和免疫荧光用于鉴定LPS。
在我们的研究中,2004年至2016年间从中国海南省共收集了169株临床分离株。结果显示,LPS基因型A是主要类型,占样本的91.1%,而LPS基因型B仅占8.9%。大多数患者为男性,被诊断为败血症或肺炎。银染和GC - MS表明,LPS基因型A和B表现出不同的表型和分子结构。免疫荧光测试表明,LPS基因型A和B之间没有交叉反应。
这是中国基于O抗原的分子流行病学的首次报告。追踪不同LPS基因型的区域分布为基于LPS的疫苗的开发和管理提供了重要见解。